Literature DB >> 23421678

SUN11602, a novel aniline compound, mimics the neuroprotective mechanisms of basic fibroblast growth factor.

Norihito Murayama1, Taisuke Kadoshima, Naohiro Takemoto, Shiho Kodama, Tetsuya Toba, Ryoko Ogino, Takafumi Noshita, Tetsushi Oka, Shinya Ueno, Mariko Kuroda, Yoshiari Shimmyo, Yasuhiro Morita, Teruyoshi Inoue.   

Abstract

Basic fibroblast growth factor (bFGF) offers some measure of protection against excitotoxic neuronal injuries by upregulating the expression of the calcium-binding protein calbindin-D28k (Calb). The newly synthesized small molecule 4-({4-[[(4-amino-2,3,5,6-tetramethylanilino)acetyl](methyl)amino]-1-piperidinyl}methyl)benzamide (SUN11602) mimics the neuroprotective effects of bFGF, and thus, we examined how SUN11602 exerts its actions on neurons in toxic conditions of glutamate. In primary cultures of rat cerebrocortical neurons, SUN11602 and bFGF prevented glutamate-induced neuronal death. This neuroprotection, which occurred in association with the augmented phosphorylation of the bFGF receptor-1 (FGFR-1) and the extracellular signal-regulated kinase-1/2 (ERK-1/2), was abolished by pretreatment with PD166866 (a FGFR-1 tyrosine kinase-specific inhibitor) and PD98059 (a mitogen-activated protein kinase [MAPK]/[ERK-1/2] kinase [MEK] inhibitor). In addition, SUN11602 and bFGF increased the levels of CALB1 gene expression in cerebrocortical neurons. Whether this neuroprotection was linked to Calb was investigated with primary cultures of cerebrocortical neurons from homozygous knockout (Calb(-/-)) and wild-type (WT) mice. In WT mice, SUN11602 and bFGF increased the levels of newly synthesized Calb in cerebrocortical neurons and suppressed the glutamate-induced rise in intracellular Ca(2+). This Ca(2+)-capturing ability of Calb allowed the neurons to survive severe toxic conditions of glutamate. In contrast, Calb levels remained unchanged in Calb(-/-) mice after exposure to SUN11602 or bFGF, and due to a loss of function of the gene, these neurons were no longer resistant to toxic conditions of glutamate. These findings indicated that SUN11602 activated a number of cellular molecules (FGFR-1, MEK/ERK intermediates, and Calb) and consequently contributed to intracellular Ca(2+) homeostasis as observed in the case of bFGF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23421678      PMCID: PMC3582292          DOI: 10.1021/cn300183k

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  60 in total

Review 1.  The MAPK signaling cascade.

Authors:  R Seger; E G Krebs
Journal:  FASEB J       Date:  1995-06       Impact factor: 5.191

Review 2.  The mitogen-activated protein kinase signal transduction pathway.

Authors:  R J Davis
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

3.  Calbindin-D28K inhibits apoptosis in dopaminergic neurons by activation of the PI3-kinase-Akt signaling pathway.

Authors:  S Sun; F Li; X Gao; Y Zhu; J Chen; X Zhu; H Yuan; D Gao
Journal:  Neuroscience       Date:  2011-10-12       Impact factor: 3.590

4.  Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats.

Authors:  M Fisher; M E Meadows; T Do; J Weise; V Trubetskoy; M Charette; S P Finklestein
Journal:  J Cereb Blood Flow Metab       Date:  1995-11       Impact factor: 6.200

5.  Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

Authors:  M P Mattson; K J Tomaselli; R E Rydel
Journal:  Brain Res       Date:  1993-09-03       Impact factor: 3.252

6.  Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats.

Authors:  N Koketsu; D J Berlove; M A Moskowitz; N W Kowall; C G Caday; S P Finklestein
Journal:  Ann Neurol       Date:  1994-04       Impact factor: 10.422

7.  Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity.

Authors:  A Freese; S P Finklestein; M DiFiglia
Journal:  Brain Res       Date:  1992-03-20       Impact factor: 3.252

8.  Treatment with basic fibroblastic growth factor following focal cerebral ischemia does not prevent neuronal injury.

Authors:  H Tenjin; R E Anderson; F B Meyer
Journal:  J Neurol Sci       Date:  1995-01       Impact factor: 3.181

9.  Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.

Authors:  Z Xia; M Dickens; J Raingeaud; R J Davis; M E Greenberg
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

10.  Crystal structure of human platelet-derived growth factor BB.

Authors:  C Oefner; A D'Arcy; F K Winkler; B Eggimann; M Hosang
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  3 in total

Review 1.  New insights into the role of fibroblast growth factors in Alzheimer's disease.

Authors:  Ramy Alam; Yara Mrad; Hussein Hammoud; Zahraa Saker; Youssef Fares; Elias Estephan; Hisham F Bahmad; Hayat Harati; Sanaa Nabha
Journal:  Mol Biol Rep       Date:  2021-11-03       Impact factor: 2.316

Review 2.  Fibroblast growth factors in the management of spinal cord injury.

Authors:  Yulong Zhou; Zhouguang Wang; Jiawei Li; Xiaokun Li; Jian Xiao
Journal:  J Cell Mol Med       Date:  2017-10-24       Impact factor: 5.310

3.  SUN11602, a bFGF mimetic, modulated neuroinflammation, apoptosis and calcium-binding proteins in an in vivo model of MPTP-induced nigrostriatal degeneration.

Authors:  Alessio Ardizzone; Valentina Bova; Giovanna Casili; Alessia Filippone; Michela Campolo; Marika Lanza; Emanuela Esposito; Irene Paterniti
Journal:  J Neuroinflammation       Date:  2022-05-07       Impact factor: 9.587

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.